On Friday, the FDA approved Bayer’s dual neurokinin (NK) targeted therapy elinzanetant, which will now be marketed in the U.S ...
Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of ...
Germany's Bayer said on Friday the U.S. Food and Drug Administration has approved its drug for menopause relief.
(per RECIST v1.1) at the 100 mg APR-1051 dose level in heavily pretreated gastrointestinal and gynecologic malignancies Disease stabilization observed in patients with tumors harboring mutations ...
Migraine Again on MSN
The Complete Guide to Migraine Relief: What’s New and What’s Still Tried-and-True
There are many effective acute and preventive migraine treatment options available today, including whole new medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback